LYTIR

Company · ENGN

enGene Therapeutics Inc.

Nasdaq's symbol directory lists ENGN on Nasdaq as “enGene Therapeutics Inc. - Common Stock”.

In the 12 months to Nov 19, 2026: insiders bought on 1 occasion ($10K); 6 filings by holders of 5% or more; 1 company report (Form 8-K, since May 26, 2026).

All insider filings at the SEC

Insider trades · SEC Form 4

Those inside the hall

Open-market purchases and sales only. Legs one person filed for one day are combined.

Who traded

  1. William Grossman, Interim Chief Medical Officer bought on 1 day latest Sep 22, 2026 bought $10K
Every trade (1)
  1. BUYWilliam Grossman, Interim Chief Medical Officer bought Sep 22, 2026 5,102 shares filing $10K

Large holders · SEC Schedules 13D and 13G

Five percent and over

Anyone who comes to hold more than 5% of a company's voting shares must tell the SEC. A Schedule 13D is filed by a holder who may seek to influence the company; a 13G by one who states it is a passive investor. An amendment updates an earlier filing, and a stake reported as 0% means the holder says it has sold all, or nearly all, of its shares. Every recent 13D and 13G

  1. Eventide Asset Management, LLC filed Nov 13, 2026 Schedule 13G passive filing 5.1%
  2. Perceptive Advisors LLC filed Aug 14, 2026 Schedule 13G/A passive filing 9.99%
  3. Venrock Healthcare Capital Partners III, L.P. filed Aug 14, 2026 Schedule 13G/A passive filing 0%
  4. Deep Track Capital, LP filed Aug 14, 2026 Schedule 13G/A passive 0 shares filing 0%
  5. Invus Global Management, LLC filed Aug 13, 2026 Schedule 13G/A passive filing 8.2%
  6. Blue Owl Capital Holdings LP filed Aug 12, 2026 Schedule 13G/A passive filing 0.76%

Company reports · SEC Form 8-K

In its own words

Current reports the company filed with the SEC; most items are due within four business days of the event. Each line lists the report's items by the SEC's own titles; the filing says what happened. Reports collected since May 26, 2026; every 8-K at the SEC.

  1. Results of operations and financial condition; Regulation FD disclosure; Other events filing Nov 12, 2026

Sources: SEC EDGAR (Forms 4, 144 and 8-K) and STOCK Act periodic transaction reports. Filings can be late, amended or wrong at the source; see methodology.